List of Clario eTMF Customers
Philadelphia, 19103, PA,
United States
Since 2010, our global team of researchers has been studying Clario eTMF customers around the world, aggregating massive amounts of data points that form the basis of our forecast assumptions and perhaps the rise and fall of certain vendors and their products on a quarterly basis.
Each quarter our research team identifies companies that have purchased Clario eTMF for Clinical Trial Management from public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources, including the customer size, industry, location, implementation status, partner involvement, LOB Key Stakeholders and related IT decision-makers contact details.
Companies using Clario eTMF for Clinical Trial Management include: BioClinica, a United States based Professional Services organisation with 2500 employees and revenues of $400.0 million, Plu Ophthalmic, a United States based Healthcare organisation with 25 employees and revenues of $1.0 million, Aurion Biotech, a United States based Life Sciences organisation with 75 employees and revenues of $1.0 million and many others.
Contact us if you need a completed and verified list of companies using Clario eTMF, including the breakdown by industry (21 Verticals), Geography (Region, Country, State, City), Company Size (Revenue, Employees, Asset) and related IT Decision Makers, Key Stakeholders, business and technology executives responsible for the software purchases.
The Clario eTMF customer wins are being incorporated in our Enterprise Applications Buyer Insight and Technographics Customer Database which has over 100 data fields that detail company usage of software systems and their digital transformation initiatives. Apps Run The World wants to become your No. 1 technographic data source!
Apply Filters For Customers
| Logo | Customer | Industry | Empl. | Revenue | Country | Vendor | Application | Category | When | SI | Insight |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Aurion Biotech | Life Sciences | 75 | $1M | United States | Clario | Clario eTMF | Clinical Trial Management | 2024 | n/a |
In 2024, Aurion Biotech implemented Clario eTMF within a Clinical Trial Management deployment to support its Phase I/II program in North America. The engagement positioned Clario eTMF as the central document repository for clinical operations, targeting improved oversight and streamlined document lifecycle management across the program.
Aurion configured Clario eTMF to enforce indexed document structures, metadata-driven filing, audit trail capture, and automated reconciliation routines consistent with Clinical Trial Management workflows. The implementation leveraged the Mentor technology that incorporates the former Clario eClinical eTMF capabilities, enabling standard eTMF functionality such as document version control, access governance, and regulatory-ready artifact traceability.
Aurion partnered with Sitero to centralize EDC and vendor data, explicitly integrating laboratory and imaging vendor feeds and deploying SiteroAI and Mentor integrations to accelerate oversight and reduce data review time. Operational coverage included clinical operations and data management teams supporting the Phase I/II studies in North America, with integrations connecting EDC sources and third-party vendor data into the centralized eTMF fabric.
Governance and process changes focused on centralizing reconciliation workflows and reducing manual cross-system reconciliation, with the case study documenting faster implementation and measurable time savings. The deployment emphasized operational consolidation of document and data review processes within Clario eTMF to support tighter oversight and reduced manual effort in clinical operations.
|
 |
BioClinica | Professional Services | 2500 | $400M | United States | Clario | Clario eTMF | Clinical Trial Management | 2015 | n/a |
In 2015, BioClinica implemented Clario eTMF in a Clinical Trial Management deployment to centralize study document handling across its United States operations. The implementation integrated Clario eTMF with OnPoint CTMS to create a unified CTMS/eTMF environment focused on clinical study document management and faster study start up.
The Clario eTMF deployment emphasized core electronic trial master file capabilities, including document lifecycle management, indexed filing with metadata, version control, audit trails, and role based access controls. Configuration aligned eTMF workflows with study start up processes to support electronic filing, sponsor and site document exchange, and streamlined approvals for site activation.
Integration architecture connected the Clario eTMF repository to OnPoint CTMS record and workflow objects, enabling synchronization of study metadata and document status across systems. Operational coverage centered on clinical operations and study start up teams within the United States, extending collaboration to sponsors and investigative sites as part of a unified document management plane.
Governance was adjusted to operate across the CTMS and eTMF boundary, consolidating responsibilities for document indexing, retention, and quality checks within joint CTMS eTMF processes. The integration announcement in October 2015 cites explicit eTMF usage and reports improved start up speed, increased efficiency, and cost savings for sponsors and sites as outcomes of the unified Clinical Trial Management environment.
|
|
|
Plu Ophthalmic | Healthcare | 25 | $1M | United States | Clario | Clario eTMF | Clinical Trial Management | 2024 | n/a |
In 2024, Plu Ophthalmic implemented Clario eTMF as part of a Clinical Trial Management deployment to support an ophthalmic device study in the United States. The engagement is documented in Sitero’s case study, which describes use of Mentor EDC together with Mentor CTMS and eTMF as the delivery vehicle for the solution.
Clario eTMF served as the eTMF component within the CTMS/eTMF stack, delivering core eTMF capabilities typical for Clinical Trial Management including centralized trial document management, metadata indexing, version control and audit trail functionality. The case study notes Sitero integrated Clario’s eClinical and eTMF technology into the Mentor CTMS/eTMF platform following Sitero’s 2023 acquisition, enabling tighter coordination between EDC and eTMF workflows and a unified CTMS and eTMF delivery.
Operational scope focused on clinical operations, site activation and enrollment activities for the U.S. study, with the implementation supporting site activation workflows and study document lifecycle processes. Governance emphasized unified clinical and technology support between Plu Ophthalmic and Sitero, and the case study reports the program accelerated the device trial, improved site activation and achieved enrollment targets.
|
Buyer Intent: Companies Evaluating Clario eTMF
Discover Software Buyers actively Evaluating Enterprise Applications
| Logo | Company | Industry | Employees | Revenue | Country | Evaluated | ||
|---|---|---|---|---|---|---|---|---|
| No data found | ||||||||